BlackRock Investment Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$16.2M Buy
438,031
+18,449
+4% +$659K 0.02% 807
2016
Q3
$14.5M Buy
419,582
+2,110
+0.5% +$73.9K 0.02% 774
2016
Q2
$13.6M Buy
417,472
+17,593
+4% +$539K 0.02% 774
2016
Q1
$11.5M Sell
399,879
-26,247
-6% -$699K 0.01% 855
2015
Q4
$14.2M Buy
426,126
+77,525
+22% +$2.41M 0.02% 735
2015
Q3
$9.91M Buy
348,601
+66,149
+23% +$2.31M 0.01% 935
2015
Q2
$11.4M Buy
282,452
+156,807
+125% +$7.04M 0.01% 925
2015
Q1
$6.18M Buy
125,645
+268
+0.2% +$12.4K 0.01% 1229
2014
Q4
$5.7M Buy
+125,377
New +$4.93M 0.01% 1279

Other funds holding AVNS

BlackRock Investment Management's AVNS Position: Q4 2016 in Review

BlackRock Investment Management increased its Avanos Medical (AVNS) stake by 4.4% in Q4 2016, buying an estimated $659K and bringing the position to 438,031 shares worth $16.2M. The position accounts for 0.02% of the portfolio, ranked #807.

BlackRock Investment Management first reported a position in AVNS in Q4 2014 and has held it in 9 quarters since. 360 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

  • BlackRock Investment Management held 438,031 shares of Avanos Medical worth $16.2M as of Q4 2016.
  • BlackRock Investment Management bought 18,449 Avanos Medical shares in Q4 2016, an estimated $659K.
  • Avanos Medical made up 0.02% of BlackRock Investment Management's portfolio in Q4 2016, its #807 holding.
  • BlackRock Investment Management first reported a position in Avanos Medical in Q4 2014 and has held it in 9 quarters since.
  • 360 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.